Back to mobile site

Depomed (DEPO) Tops Q4 EPS by 12c

February 21, 2017 4:02 PM EST

Depomed (NASDAQ: DEPO) reported Q4 EPS of $0.48, $0.12 better than the analyst estimate of $0.36. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $123.28 million.

For earnings history and earnings-related data on Depomed (DEPO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings